Jason Najum talks to Srinivas Rao, CEO of Atai Life Sciences, a biotech company focused on mental health and psychedelic compounds.

Stifel has initiated Compass Pathways (NASDAQ:CMPS) with a buy rating saying that stakeholders are starting to agree there is ...

Ketamine, a dissociative anesthetic, has carved itself a spot in the world of mental health care over the past two decades.

Johnson & Johnson’s seltorexant is one of two new therapies that the company reckons could become blockbuster treatments for depression, and data from a phase 3 trial keeps that hope alive.

Missouri lawmakers consider a study on psilocybin therapy to aid veterans with PTSD and depression. Despite initial ...

Who is Bryan Johnson, the tech CEO who spent millions on anti-ageing venture - The entrepreneur has recently revealed what he ...

Shares in Axsome Therapeutics have rocketed on FDA approval of its depression therapy Auvelity ... That status goes to Johnson & Johnson's Spravato (esketamine), which was approved in March ...

Antidepressants and years of counseling could be helpful, but it is not turning the tide.” By Rebecca Rivas, Missouri Independent In hopes of helping veterans facing mental health issues, Missouri ...

While the first Anchorage gathering took place in 1936, it wasn’t specifically called Fur Rendezvous until 1938.

Reality TV star and business mogul Kim Kardashian is facing a lawsuit over allegations that she falsely identified a New York ...

Clint Hill, the U.S. Secret Service agent who leaped atop John Kennedy's limousine to shield the mortally wounded president and long wondered if he could have saved him by acting quicker, has died at ...